ReNeuron and Cell Therapy Catapult partnered develop and optimize the processes required to scale up manufacture of ReNeuron's CTXcell line

ReNeuron Group plc

U.K. / Small-Cap Biopharma (<$1 billion)

$35.4m on 03/29/2013 [market cap]

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Cell Therapy Catapult

U.K. / Private Biopharma

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced